MYND Life Sciences Inc. MYNDF
Set alert
0.01 USD 0.00 0.00%
At close · Oct 29
0.045 Day range 0.0675
0.0081 52-week range 0.021
- YTD
- 0.00%
- 1 year
- -41.30%
- Open
- 0.045
- Prev close
- 0.0081
- Mkt cap
- 387.32K
- Vol
- 7.92K
- Avg vol
- 0
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.045
- High
- 0.0675
Financial health
Altman Z-Score
-36.44 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.0×
FY 2019 5y median -10.0× FY 2023
P/S 17.0×
FY 2019 5y median 0.0× FY 2023
P/B -0.3×
FY 2019 5y median -515× FY 2023
P/FCF -8.0×
FY 2019 5y median -14.0× FY 2023
EV/EBITDA -2.5×
FY 2019 5y median -2.0× FY 2023
EV/Sales 49.3×
FY 2019 5y median 0.0× FY 2023
FCF Yield -12.5%
FY 2019 5y median -7.2% FY 2023
Profitability
Gross Margin -258.1%
FY 2019 5y median 0.0% FY 2023
Operating Margin -1966.6%
FY 2019 5y median 0.0% FY 2023
Net Margin -1632.3%
FY 2019 5y median 0.0% FY 2023
ROE 30.5%
FY 2019 5y median 105.3% FY 2023
ROIC 92.5%
FY 2019 5y median 105.3% FY 2023
ROA -190.3%
FY 2019 5y median -190.3% FY 2023
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2023
Operating Income 39.1%
FY 2019 FY 2023
EPS (diluted) 58.0%
FY 2019 FY 2023
Free Cash Flow 89.1%
FY 2019 FY 2023
Financial Health
Current Ratio 0.1×
FY 2019 5y median 0.1× FY 2023
Quick Ratio 0.1×
FY 2019 5y median 0.1× FY 2023
Debt / Equity -0.6×
FY 2019 5y median -0.6× FY 2023
Net Debt / EBITDA -1.7×
FY 2019 5y median -0.1× FY 2023
Interest Coverage -2.5×
FY 2019 5y median -2.5× FY 2023
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2023
Annual · latest fiscal year ends 2023-10-31